Worth reading
39Recurring
Scored from 4 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedU.S. GAAPNet Sales3,433,357¥ millionYear on year +4.0%Progress 72.0%
Operating profit327,684¥ millionYear on year +8.4%Progress 71.9%
Ordinary income358,442¥ millionYear on year +14.1%Progress 74.2%
Net income attributable to owners of the parent246,409¥ millionYear on year +12.2%Progress 74.0%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥287.24
Financial position at period-end
Total assets6,364,771¥ million
of which net assets 3,531,808 ¥ millionEquity ratio 52.3%vs. prior year-end -4.6pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+231,413
Investment-165,018
Financials+55,044
Net change+121,439
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥697,505 million
Segment revenuePrinting ¥1,867,421 million (YoY +2.3%), Medical ¥407,363 million (YoY -1.2%), Imaging ¥847,617 million (YoY +16.7%), Industrial ¥218,891 million (YoY -10.7%), Other and Corporate ¥175,523 million (YoY +2.0%)
Segment profitPrinting ¥208,158 million (YoY +3.0%), Medical ¥10,790 million (YoY -40.6%), Imaging ¥144,394 million (YoY +33.2%), Industrial ¥30,105 million (YoY -24.8%), Other and Corporate ¥-65,688 million
Regional sales¥699,168 million (YoY 0.0%), ¥2,734,189 million (YoY +5.0%), ¥1,123,274 million (YoY +6.1%), ¥908,433 million (YoY +4.9%), ¥702,482 million (YoY +3.4%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥4,766,000 million (YoY +3.1%)
Operating profit¥456,000 million (YoY +0.1%)
Ordinary income¥483,000 million (YoY +0.2%)
Net income¥333,000 million (YoY +0.3%)
Annual Dividend Forecast¥160 → ¥160（0.0%）
Payout ratio40
Shareholder Return PolicyStable and proactive shareholder returns, targeting a payout ratio of 40% without reducing dividends
Factors Behind Changes in Business Performance
For an explanation of the factors behind changes in overall performance, please refer to the presentation materials. Due to a change in the depreciation method, depreciation and amortization expense for the nine months ended the third quarter decreased by ¥20,901 million, while quarterly net income attributable to the Company's shareholders increased by ¥14,436 million.
Disclosure regarding the going concern assumption
None
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 None見積りの変更 Yes修正再表示 None
Depreciation and amortization¥172,056 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (participants not specified)
Issued Shares at Period-End1,333,763,464 shares
Treasury Shares at Period-End500,439,561 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | U.S. GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥3,433,357 million (YoY +4.0%) |
| Operating profit | ¥327,684 million (YoY +8.4%) |
| Ordinary income | ¥358,442 million (YoY +14.1%) |
| Profit attributable to owners of the parent | ¥246,409 million (YoY +12.2%) |
| Net income per share | ¥287.24 |
| Equity ratio | End of the current fiscal period 52.3 / End of previous period 56.9 |
| Total assets | ¥6,364,771 million |
| Net assets | ¥3,531,808 million |
| Cash flows from operating activities | ¥231,413 million |
| Cash flows from investing activities | ¥-165,018 million |
| Cash flows from financing activities | ¥55,044 million |
| Cash and cash equivalents at end of period | ¥697,505 million |
| Full-year earnings forecast | Net Sales ¥4,766,000 million (YoY +3.1%) / Operating profit ¥456,000 million (YoY +0.1%) / Ordinary income ¥483,000 million (YoY +0.2%) / Net income ¥333,000 million (YoY +0.3%) |
| Annual Dividend Forecast | ¥160 → ¥160（0.0%） |
| Payout ratio | 40 |
| Shareholder Return Policy | Stable and proactive shareholder returns, targeting a payout ratio of 40% without reducing dividends |
| Segment revenue | Printing ¥1,867,421 million (YoY +2.3%), Medical ¥407,363 million (YoY -1.2%), Imaging ¥847,617 million (YoY +16.7%), Industrial ¥218,891 million (YoY -10.7%), Other and Corporate ¥175,523 million (YoY +2.0%) |
| Segment profit | Printing ¥208,158 million (YoY +3.0%), Medical ¥10,790 million (YoY -40.6%), Imaging ¥144,394 million (YoY +33.2%), Industrial ¥30,105 million (YoY -24.8%), Other and Corporate ¥-65,688 million |
| Regional sales | ¥699,168 million (YoY 0.0%), ¥2,734,189 million (YoY +5.0%), ¥1,123,274 million (YoY +6.1%), ¥908,433 million (YoY +4.9%), ¥702,482 million (YoY +3.4%) |
| Depreciation and amortization | ¥172,056 million |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes None / Change in accounting estimate Yes / Restatement None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (participants not specified) |
| Issued Shares at Period-End | 1,333,763,464 shares |
| Treasury Shares at Period-End | 500,439,561 shares |
| Factors Behind Changes in Business Performance | For an explanation of the factors behind changes in overall performance, please refer to the presentation materials. Due to a change in the depreciation method, depreciation and amortization expense for the nine months ended the third quarter decreased by ¥20,901 million, while quarterly net income attributable to the Company's shareholders increased by ¥14,436 million. |
Items this document does not state (7)
Operating MarginRevision to Earnings ForecastOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Changes in the scope of consolidationMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The audit firm has completed its interim review of the quarterly consolidated financial statements.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.